Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Pharmacology of Alzheimer's disease: where do we go from here?].
Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini-Stula A, Bentué-Ferrer D, Bordet R, Allain H. Sellal F, et al. Among authors: geerts h. Therapie. 2005 Mar-Apr;60(2):89-107. doi: 10.2515/therapie:2005013. Therapie. 2005. PMID: 15969312 Review. French.
Pharmacology of Alzheimer's disease: appraisal and prospects.
Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini Stula A, Bordet R, Bentué-Ferrer D, Allain H. Sellal F, et al. Among authors: geerts h. Dement Geriatr Cogn Disord. 2005;19(5-6):229-45. doi: 10.1159/000084400. Epub 2005 Mar 11. Dement Geriatr Cogn Disord. 2005. PMID: 15767760 Review.
Neuroprotection and neurodegenerative diseases: from biology to clinical practice.
Akwa Y, Allain H, Bentue-Ferrer D, Berr C, Bordet R, Geerts H, Nieoullon A, Onteniente B, Vercelletto M. Akwa Y, et al. Among authors: geerts h. Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):226-39. doi: 10.1097/01.wad.0000189053.25817.d6. Alzheimer Dis Assoc Disord. 2005. PMID: 16327350 Review.
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
Vergallo A, Mégret L, Lista S, Cavedo E, Zetterberg H, Blennow K, Vanmechelen E, De Vos A, Habert MO, Potier MC, Dubois B, Neri C, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Vergallo A, et al. Alzheimers Dement. 2019 Jun;15(6):764-775. doi: 10.1016/j.jalz.2019.03.009. Epub 2019 May 18. Alzheimers Dement. 2019. PMID: 31113759
The Alzheimer Precision Medicine Initiative.
Hampel H, Vergallo A, Perry G, Lista S; Alzheimer Precision Medicine Initiative (APMI). Hampel H, et al. J Alzheimers Dis. 2019;68(1):1-24. doi: 10.3233/JAD-181121. J Alzheimers Dis. 2019. PMID: 30814352 Review.
AIT-082 NeoTherapeutics Inc.
Geerts H. Geerts H. IDrugs. 1998 Oct;1(6):694-9. IDrugs. 1998. PMID: 18465624
127 results